Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 378

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Long-Term Efficacy of a Hepatitis E Vaccine

Open access
Zhang, Jun, Zhang, Xue-Feng, Huang, Shou-Jie, Wu, Ting, Hu, Yue-Mei, Wang, Zhong-Ze, Wang, Hua, Jiang, Han-Min, Wang, Yi-Jun, Yan, Qiang, Guo, Meng, Liu, Xiao-Hui, Li, Jing-Xin, Yang, Chang-Lin, Tang, Quan, Jiang, Ren-Jie, Pan, Hui-Rong, Li, Yi-Min, Shih, J. Wai-Kuo, Ng, Mun-Hon, Zhu, Feng-Cai, Xia, Ning-Shao · 2015 · New England Journal of Medicine

Abstract

BACKGROUND: Hepatitis E virus (HEV) is a leading cause of acute hepatitis. The long-term efficacy of a hepatitis E vaccine needs to be determined. METHODS: In an initial efficacy study, we randomly assigned healthy adults 16 to 65 years of age to receive three doses of either a hepatitis E vaccine (vaccine group; 56,302 participants) or a hepatitis B vaccine (control group; 56,302 participants). The vaccines were administered at 0, 1, and 6 months, and the participants were followed for 19 months. In this extended follow-up study, the treatment assignments of all participants remained double-blinded, and follow-up assessments of efficacy, immunogenicity, and safety were continued for up to 4.5 years. RESULTS: During the 4.5-year study period, 60 cases of hepatitis E were identified; 7 cases were confirmed in the vaccine group (0.3 cases per 10,000 person-years), and 53 cases in the control group (2.1 cases per 10,000 person-years), representing a vaccine efficacy of 86.8% (95% confidence interval, 71 to 94) in the modified intention-to-treat analysis, rather than (95% confidence interval, 71 to 84) [corrected]. Of the participants who were assessed for immunogenicity and were seronegative at baseline, 87% of those who received three doses of the hepatitis E vaccine maintained antibodies against HEV for at least 4.5 years; HEV antibody titers developed in 9% in the control group. The rate of adverse events was similar in the two groups. CONCLUSIONS: Immunization with this hepatitis E vaccine induced antibodies against HEV and provided protection against hepatitis E for up to 4.5 years. (Funded by the Chinese Ministry of Science and Technology and others; ClinicalTrials.gov number, NCT01014845.).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmoa1406011

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 14 references

Cited by

See all 378

Metadata

Authors
Zhang, J., Zhang, X.-F., Huang, S.-J., Wu, T., Hu, Y.-M., Wang, Z.-Z., Wang, H., Jiang, H.-M., Wang, Y.-J., Yan, Q., Guo, M., Liu, X.-H., Li, J.-X., Yang, C.-L., Tang, Q., Jiang, R.-J., Pan, H.-R., Li, Y.-M., Shih, J. W.-K., Ng, M.-H., Zhu, F.-C., & Xia, N.-S.
Venue
New England Journal of Medicine
Published
2015-03-05
Volume
372
Issue
10
Pages
914-922
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2139975677
Cited by
378
References
14
FWCI
23.54
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Long-Term Efficacy of a Hepatitis E Vaccine. https://app.cochat.ai/papers/10.1056/nejmoa1406011
The paper
Zhang, J., Zhang, X.-F., Huang, S.-J., Wu, T., Hu, Y.-M., Wang, Z.-Z., Wang, H., Jiang, H.-M., Wang, Y.-J., Yan, Q., Guo, M., Liu, X.-H., Li, J.-X., Yang, C.-L., Tang, Q., Jiang, R.-J., Pan, H.-R., Li, Y.-M., Shih, J. W.-K., . . . Xia, N.-S. (2015). Long-Term Efficacy of a Hepatitis E Vaccine. New England Journal of Medicine. https://doi.org/10.1056/nejmoa1406011

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.